Engineering Antigen-Specific Tolerance to an Artificial Protein Hydrogel.

Area of Science:

• Biomaterials Science
• Immunology
• Tissue Engineering

Background:

• Artificial protein hydrogels are promising biomaterials for tissue engineering and regenerative medicine.
• Their immunogenicity, often due to novel amino acid sequences, poses a challenge for clinical applications.

Purpose of the Study:

• To engineer artificial protein hydrogels with predictable immune outcomes.
• To investigate methods for controlling the immune response to these biomaterials in vivo.

Main Methods:

• Engineered injectable "self" and "nonself" artificial protein hydrogels based on amino acid sequence.
• Implanted hydrogels in mice and measured antigel antibody titers.
• Administered a fusion antibody targeting nonself hydrogel epitopes to DEC-205 to assess tolerance induction.

Main Results:

• "Nonself" hydrogels elicited significantly higher antigel antibody titers compared to "self" hydrogels.
• Prophylactic administration of the fusion antibody targeting DEC-205 completely suppressed antibody production against "nonself" hydrogels.
• Demonstrated successful induction of antigen-specific tolerance.

Conclusions:

• The immune response to artificial protein biomaterials can be modulated.
• Antigen-specific tolerance can be induced, offering a strategy to mitigate immunogenicity.
• This approach holds potential for the safe clinical translation of advanced protein-based biomaterials.